On Oct. 12, 2021, Moderna announced that Gavi, the Vaccine Alliance had exercised its option to purchase an additional 176.5 million doses of the Moderna COVID-19 vaccine for the COVAX Facility.

Of these additional doses, 116.5 million doses were expected to be delivered in the first quarter of 2022 and 60 million doses were expected to be delivered in the second quarter of 2022. All doses were offered at Modernaﾒs lowest tiered price.